Latest news with #MadisonMuller
Bloomberg
a day ago
- Health
- Bloomberg
WeightWatchers Customers Now Have Access to Wegovy at a Cheaper Price
By and Madison Muller Save Novo Nordisk A/S added a deal with WeightWatchers to boost access to its Wegovy obesity drug, just days after axing a collaboration with telehealth company Hims & Hers Health Inc. WeightWatchers subscribers will be able to access Wegovy via CenterWell Pharmacy from July 1, Novo said Thursday. The drugmaker is also offering a $299 introductory price to self-pay patients who start on Wegovy, as well as for people who redeemed an earlier $199 offer and need a refill.
Yahoo
16-05-2025
- Business
- Yahoo
Novo Ousts CEO Jorgensen Over Competition, Share Price
Novo Nordisk is replacing Chief Executive Officer Lars Fruergaard Jorgensen amid increased competition for its Wegovy obesity shots. The move follows a 53% decline in its share price over the past 12 months that has sliced more than $300 billion off its market value. Madison Muller reports on Bloomberg Television. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30-04-2025
- Business
- Yahoo
Hims & Hers Soars on Reduced Price Deal for Novo's Wegovy
Hims & Hers Health surged after Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a reduced price on several telehealth platforms at a 63% discount from the drug's US list price, before additional subscription fees. Madison Muller reports on Bloomberg Television. Sign in to access your portfolio
